Recruiting now—All ages

Metastatic Leiomyosarcoma Biomarker Protocol

Sponsor: University of Michigan Rogel Cancer Center · NCT05653388 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Leiomyosarcoma

What it tests

Plasma Collectionother

Where it's running11 sites

Sarcoma Oncology Research Center
Santa Monica, California 90403
Recruiting now
- Allyssa Lingad(contact)310-552-9999 [email protected]
- Sant P Chawla, MD(principal investigator)
University of Miami
Miami, Florida 33136
Recruiting now
- Gina D'Amato, MD(contact)
- Gina D'Amato, MD(principal investigator)
Dana- Farber
Boston, Massachusetts 02215
Recruiting now
- David Shulman, MD(contact)
University of Michigan Cancer Center
Ann Arbor, Michigan 48109
Recruiting now
- Scott Schuetze, M.D., PhD.(contact)734-647-8925
- Scott Schuetze, M.D., PhD(principal investigator)
Mayo Clinic
Rochester, Minnesota 55901
Recruiting now
- Brittany Siontis, MD(contact)
Memorial Sloan Kettering Cancer Center
New York, New York 10065
Recruiting now
- Sujana Movva, MD(contact)
Ohio State University
Columbus, Ohio 43210
Recruiting now
- Gabriel Tinoco, MD(contact)
Vanderbilt University Medical Center
Nashville, Tennessee 37232
Recruiting now
- Elizabeth J Davis, MD(contact)615-322-5000
MD Anderson
Houston, Texas 77030
Recruiting now
- Elise Nassif Haddad, MD, PhD(contact)281-460-0607 [email protected]

2 international sites

Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia 2050
Recruiting now
- Peter Grimison(contact)[email protected]
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia 3000
Recruiting now
- Stephen Luen(contact)[email protected]

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Patients with unresectable or metastatic leiomyosarcoma (LMS). There is no age requirement
* Receiving first-line chemotherapy with doxorubicin or gemcitabine/docetaxel
* Target lesions per RECIST 1.1
* Optional archival tumor tissue including 1 H\&E-stained slide and unstained tumor tissue \[either tissue block containing tumor, or minimum of 4 unstained slides (preferably 8 unstained slides)-fresh frozen sample may also be used in lieu of FFPE sample\] available for study research

Updated 2025-12-26 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.